AttributesValues
Author
Bibliographic Citation
  • Tabouret Emeline, Figarella‑Branger Dominique, Chinot Olivier. TEMOBIC : Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study. Oncologist, AlphaMed Press, 2021, ⟨10.1002/onco.13765⟩
  • Tabouret Emeline, Fabbro Michel, Autran Didier, Hoang‐xuan Khe, Taillandier Luc, Ducray François, Barrie Maryline, Sanson Marc, Kerr Christine, Cartalat‐carel Stephanie, Loundou Anderson, Guillevin Remy, Mokhtari Karima, Figarella‑branger Dominique, Delattre Jean‐yves, Chinot Olivier . TEMOBIC : Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study . Oncologist, 2021, ⟨10.1002/onco.13765⟩
  • Tabouret Emeline, Fabbro Michel, Autran Didier, Hoang‐xuan Khe, Taillandier Luc, Ducray François, Barrie Maryline, Sanson Marc, Kerr Christine, Cartalat‐carel Stephanie, Loundou Anderson, Guillevin Remy, Mokhtari Karima, Figarella‑branger Dominique, Delattre Jean‐yves, Chinot Olivier. TEMOBIC : Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study. Oncologist, 2021, ⟨10.1002/onco.13765⟩
Title
  • TEMOBIC : Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study
dc:date
  • 2021
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software